New malaria drug put to the test in human trial
NCT ID NCT05979207
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new experimental drug called MMV367 in 12 healthy adults. Participants were intentionally infected with a controlled, low-level malaria infection to see how well the drug works and how safe it is. The goal was to measure how the body processes the drug and how quickly it clears the malaria parasites from the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-INFECTIVE AGENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
South Bank
Brisbane, Queensland, 4101, Australia
-
USC Clinical Trials, Morayfield
Brisbane, Queensland, 4506, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Grape powder may help aging immune systems — a trial puts it to the test
- Can a pill make your blood deadly to malaria mosquitoes?